The role of a formaldehyde dehydrogenase-glutathione pathway in protein S-nitrosation in mammalian cells

Nitric Oxide. 2003 Nov;9(3):172-81. doi: 10.1016/j.niox.2003.11.003.

Abstract

Intracellular sulfhydryls, both protein and non-protein, are potential targets of nitric oxide-related species. S-Nitrosation of proteins can occur in vivo and can affect their activity. Metabolic pathways that regulate protein S-nitrosation are therefore likely to be biologically important. We now report that formaldehyde dehydrogenase, an enzyme that decomposes S-nitrosoglutathione, can indirectly regulate the level of cellular protein S-nitrosation. Nitrogen oxide donors induced high levels of protein S-nitrosation in HeLa cells and lower levels in Mutatect fibrosarcoma cells, as determined by Saville-Griess assay and Western-dot-blot analysis. Depletion of glutathione by treatment with buthionine sulfoximine markedly increased protein S-nitrosation in both cell lines. Glutathione depletion also increased cytokine-induced S-nitrosation in brain endothelial cells. Formaldehyde dehydrogenase activity was 2-fold higher in Mutatect than in HeLa cells. We downregulated formaldehyde dehydrogenase activity in Mutatect cells by stably expressing antisense RNA and short-interfering RNA. In these cells, both protein S-nitrosation and S-nitrosoglutathione levels were significantly enhanced after exposure to nitrogen oxide donors as compared to parental cells. Overall, a strong inverse correlation between total S-nitrosothiols and formaldehyde dehydrogenase activity was seen. Inhibition of glutathione reductase, the enzyme that converts oxidized to reduced glutathione, by dehydroepiandrosterone similarly increased protein S-nitrosation and S-nitrosoglutathione levels in both cell lines. Our results provide the first evidence that formaldehyde dehydrogenase-dependent decomposition of S-nitrosoglutathione plays a role in protecting against nitrogen oxide-mediated protein S-nitrosation. We propose that formaldehyde dehydrogenase and glutathione reductase participate in a glutathione-dependent metabolic cycle that decreases protein S-nitrosation following exposure of cells to nitric oxide.

MeSH terms

  • Acetylcysteine / analogs & derivatives*
  • Acetylcysteine / pharmacology
  • Aldehyde Oxidoreductases / antagonists & inhibitors
  • Aldehyde Oxidoreductases / genetics
  • Aldehyde Oxidoreductases / physiology*
  • Animals
  • Buthionine Sulfoximine / pharmacology
  • Cells, Cultured
  • Cysteine / analogs & derivatives*
  • Cysteine / pharmacology*
  • Dehydroepiandrosterone / pharmacology
  • Glutathione / metabolism
  • Glutathione Reductase / physiology
  • HeLa Cells
  • Humans
  • Mice
  • Nitric Oxide / metabolism*
  • Nitric Oxide / physiology
  • Nitric Oxide Donors / pharmacology
  • Nitroprusside / pharmacology
  • Nitrosation / drug effects
  • Proteins / metabolism*
  • RNA, Small Interfering / pharmacology
  • S-Nitrosoglutathione / pharmacology*
  • S-Nitrosothiols / analysis
  • S-Nitrosothiols / metabolism*
  • S-Nitrosothiols / pharmacology*

Substances

  • Nitric Oxide Donors
  • Proteins
  • RNA, Small Interfering
  • S-Nitrosothiols
  • Nitroprusside
  • Nitric Oxide
  • Dehydroepiandrosterone
  • Buthionine Sulfoximine
  • S-nitroso-N-acetylcysteine
  • S-Nitrosoglutathione
  • S-nitrosocysteine
  • formaldehyde dehydrogenase (glutathione)
  • Aldehyde Oxidoreductases
  • Glutathione Reductase
  • Glutathione
  • Cysteine
  • Acetylcysteine